Home › Funds › JACOBS & CO/CA › JNJ

JACOBS & CO/CA position in JNJ

JOHNSON JOHNSON · Health Care

JACOBS & CO/CA reported holding 48,636 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$12.9M, representing 1.11% of its reported portfolio and ranking #29 among its reported holdings. JACOBS & CO/CA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)48.64K sh
Reported value held$12.88M
Portfolio Weight1.11%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How JACOBS & CO/CA's JNJ position evolved

JACOBS & CO/CA first disclosed a stake in JNJ in Q3 2023 at 52,938 shares (US$8.2M). The position peaked in Q3 2026 at 48,636 shares, worth US$12.9M. Across 13 filings, JACOBS & CO/CA increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 48,636 shares valued at US$12.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 52.94K $8.24M New
Q4 2023 54.86K $8.60M Add
Q1 2024 55.88K $8.84M Add
Q2 2024 57.27K $8.37M Add
Q3 2024 56.39K $9.14M Reduce
Q4 2024 56.57K $8.18M Hold
Q1 2025 54.31K $9.01M Reduce
Q2 2025 52.12K $7.96M Reduce
Q3 2025 51.64K $9.57M Reduce
Q4 2025 49.32K $10.21M Reduce
Q1 2026 48.71K $11.91M Reduce
Q2 2026 48.67K $12.36M Hold
Q3 2026 48.64K $12.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has JACOBS & CO/CA held JNJ?

JACOBS & CO/CA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JACOBS & CO/CA's current position in JNJ?

As of Q3 2026, JACOBS & CO/CA holds 48.64K shares of JNJ (JOHNSON JOHNSON), valued at $12.88M, representing 1.11% of its reported portfolio and ranking #29.

Has JACOBS & CO/CA been buying or selling JNJ?

In the latest 13F filing (Q3 2026), JACOBS & CO/CA held unchanged its position in JNJ. The position peaked in Q3 2026 at 48.64K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.